Funding for this research was provided by:
HistoSonics
Article History
Received: 4 September 2024
Accepted: 25 March 2025
First Online: 28 April 2025
Declarations
:
: T.M.W. Research grants from Boston Scientific, HistoSonics, and Johnson & Johnson; education grant from Angiodynamics. J.F.A. Chief Medical Officer of Venture Investors, an investor in Histosonics. P.F.L. HistoSonics (consultant, shareholder, sponsored research agreement), NeuWave/Ethicon/Johnson&Johnson (Consultant).